XML 213 R187.htm IDEA: XBRL DOCUMENT v3.20.4
Reportable segments (Details 1) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement [Line Items]      
Revenue $ 1,817,191 $ 1,943,655 $ 2,265,803
Cost of sales (1,334,321) (1,383,603) (1,485,631)
Gross profit 482,870 560,052 780,172
Other incomes by function 26,893 18,218 32,048
Administrative expenses (107,017) (117,180) (118,126)
Other expenses by function (99,612) (25,995) (36,907)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 4,684 (1,057) 2,967
Other gains (losses) (5,313) (383) 6,404
Financial income 13,715 26,289 22,533
Finance costs (82,199) (76,939) (57,807)
interest in the profit or loss of associates and joint ventures accounted for by the equity method 8,940 9,786 6,351
Exchange differences (4,423) (2,169) (16,597)
Profit (loss) before taxes 238,538 390,622 621,038
Income tax expense (70,179) (110,019) (178,975)
Profit (loss) from continuing operations 168,359 280,603 442,063
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 168,359 280,603 442,063
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 164,518 278,115 439,830
Profit (loss) attributable to the non-controllers 3,841 2,488 2,233
Profit (loss) 168,359 280,603 442,063
Specialty plant nutrients [Member]      
Statement [Line Items]      
Revenue 701,688 723,920 781,751
Cost of sales (537,801) (573,808) (613,267)
Gross profit 163,887 150,112 168,484
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 163,887 150,112 168,484
Income tax expense 0 0 0
Profit (loss) from continuing operations 163,887 150,112 168,484
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 163,887 150,112 168,484
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 163,887 150,112 168,484
Iodine and its derivatives [Member]      
Statement [Line Items]      
Revenue 334,657 371,020 324,972
Cost of sales (168,499) (230,468) (217,464)
Gross profit 166,158 140,552 107,508
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 166,158 140,552 107,508
Income tax expense 0 0 0
Profit (loss) from continuing operations 166,158 140,552 107,508
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 166,158 140,552 107,508
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 166,158 140,552 107,508
Lithium and its derivatives [Member]      
Statement [Line Items]      
Revenue 383,373 505,714 734,801
Cost of sales (297,048) (306,250) (316,875)
Gross profit 86,325 199,464 417,926
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 86,325 199,464 417,926
Income tax expense 0 0 0
Profit (loss) from continuing operations 86,325 199,464 417,926
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 86,325 199,464 417,926
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 86,325 199,464 417,926
Industrial chemicals [Member]      
Statement [Line Items]      
Revenue 160,608 94,875 108,267
Cost of sales (119,092) (63,590) (72,964)
Gross profit 41,516 31,285 35,303
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 41,516 31,285 35,303
Income tax expense 0 0 0
Profit (loss) from continuing operations 41,516 31,285 35,303
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 41,516 31,285 35,303
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 41,516 31,285 35,303
Potassium [Member]      
Statement [Line Items]      
Revenue 209,294 212,151 267,474
Cost of sales (187,019) (176,199) (217,386)
Gross profit 22,275 35,952 50,088
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 22,275 35,952 50,088
Income tax expense 0 0 0
Profit (loss) from continuing operations 22,275 35,952 50,088
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 22,275 35,952 50,088
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 22,275 35,952 50,088
Other products and services [Member]      
Statement [Line Items]      
Revenue 27,571 35,975 48,538
Cost of sales (24,862) (33,288) (47,675)
Gross profit 2,709 2,687 863
Other incomes by function 0 0 0
Administrative expenses 0 0 0
Other expenses by function 0 0 0
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 0 0 0
Other gains (losses) 0 0 0
Financial income 0 0 0
Finance costs 0 0 0
interest in the profit or loss of associates and joint ventures accounted for by the equity method 0 0 0
Exchange differences 0 0 0
Profit (loss) before taxes 2,709 2,687 863
Income tax expense 0 0 0
Profit (loss) from continuing operations 2,709 2,687 863
Profit (loss) from discontinued operations 0 0 0
Profit (loss) 2,709 2,687 863
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 0 0 0
Profit (loss) attributable to the non-controllers 0 0 0
Profit (loss) 2,709 2,687 863
Corporate unit [Member]      
Statement [Line Items]      
Revenue 0 0 0
Cost of sales 0 0 0
Gross profit 0 0 0
Other incomes by function 26,893 18,218 32,048
Administrative expenses (107,017) (117,180) (118,126)
Other expenses by function (99,612) (25,995) (36,907)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9 4,684 (1,057) 2,967
Other gains (losses) (5,313) (383) 6,404
Financial income 13,715 26,289 22,533
Finance costs (82,199) (76,939) (57,807)
interest in the profit or loss of associates and joint ventures accounted for by the equity method 8,940 9,786 6,351
Exchange differences (4,423) (2,169) (16,597)
Profit (loss) before taxes (244,332) (169,430) (159,134)
Income tax expense (70,179) (110,019) (178,975)
Profit (loss) from continuing operations (314,511) (279,449) (338,109)
Profit (loss) from discontinued operations 0 0 0
Profit (loss) (314,511) (279,449) (338,109)
Profit (loss), attributable to [abstract]      
Profit (loss) attributable to the controller´s owners 164,518 278,115 439,830
Profit (loss) attributable to the non-controllers 3,841 2,488 2,233
Profit (loss) $ (314,511) $ (279,449) $ (338,109)